CIK 0001615219
- Non-accelerated filer
- Smaller reporting company
Decoy Therapeutics Inc.
Sign in to watch- Ticker
- DCOY
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 465087339
- Phone
- +1 346-772-0346
- Business address
- 2450 HOLCOMBE BLVD, SUITE J-608, HOUSTON, TX, 77021
- Former names
- Salarius Pharmaceuticals, Inc., Flex Pharma, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 44 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2016-03-21 | SCULLEY JOHN Director | Purchase | +4,000 | $12.06 | $48K | 4,709 |
| 2016-03-21 | Westphal Christoph H President and CEO | Purchase | +24,107 | $11.70 | $282K | 2,887,004 |
| 2016-03-21 | Westphal Christoph H President and CEO | Purchase | +23,951 | $11.78 | $282K | 2,910,955 |
| 2016-03-18 | SCULLEY JOHN Director | Purchase | +709 | $11.13 | $8K | 709 |
| 2016-03-18 | Westphal Christoph H President and CEO | Purchase | +18,437 | $11.06 | $204K | 2,862,897 |
| 2016-03-17 | Westphal Christoph H President and CEO | Purchase | +19,137 | $10.94 | $209K | 2,844,460 |
| 2016-03-16 | Westphal Christoph H President and CEO | Purchase | +19,142 | $10.85 | $208K | 2,825,323 |
| 2016-03-15 | Westphal Christoph H President and CEO | Purchase | +19,237 | $9.62 | $185K | 2,806,181 |
| 2016-03-15 | Stacy Michelle Director | Purchase | +2,585 | $9.63 | $25K | 2,585 |
| 2016-03-14 | Wessel Thomas Chief Medical Officer | Purchase | +8,000 | $9.13 | $73K | 57,064 |
| 2016-03-11 | Longwood Fund II, L.P. 10% owner | Purchase | +89,680 | $7.00 | $628K | 2,786,944 |
| 2016-03-11 | Westphal Christoph H President and CEO | Purchase | +89,680 | $7.00 | $628K | 2,786,944 |
| 2016-03-11 | Wessel Thomas Chief Medical Officer | Purchase | +12,000 | $7.15 | $86K | 49,064 |
| 2016-03-11 | MacKinnon Roderick Director | Purchase | +10,000 | $7.03 | $70K | 431,277 |
| 2016-03-05 | Stacy Michelle Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2016-01-21 | Westphal Christoph H President and CEO | Grant or award · Stock Option (right to buy) | +164,000 | 164,000 | ||
| 2016-01-21 | McCabe John P. VP of Finance & Treasurer | Grant or award · Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2016-01-21 | Woo Elizabeth SVP, Investor Relations | Grant or award · Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2016-01-21 | Wessel Thomas Chief Medical Officer | Grant or award · Stock Option (right to buy) | +52,000 | 52,000 | ||
| 2016-01-21 | Lindemann Katharine Chief Operating Officer | Grant or award · Stock Option (right to buy) | +13,125 | 13,125 |
Page 11 of 12 · 229 trades